These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 21611732)
1. Association of ADAM10 and CAMK2A polymorphisms with conduct disorder: evidence from family-based studies. Jian XQ; Wang KS; Wu TJ; Hillhouse JJ; Mullersman JE J Abnorm Child Psychol; 2011 Aug; 39(6):773-82. PubMed ID: 21611732 [TBL] [Abstract][Full Text] [Related]
2. NTM and NR3C2 polymorphisms influencing intelligence: family-based association studies. Pan Y; Wang KS; Aragam N Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):154-60. PubMed ID: 21036197 [TBL] [Abstract][Full Text] [Related]
3. An ADAM10 promoter polymorphism is a functional variant in severe sepsis patients and confers susceptibility to the development of sepsis. Cui L; Gao Y; Xie Y; Wang Y; Cai Y; Shao X; Ma X; Li Y; Ma G; Liu G; Cheng W; Liu Y; Liu T; Pan Q; Tao H; Liu Z; Zhao B; Shao Y; Li K Crit Care; 2015 Mar; 19(1):73. PubMed ID: 25888255 [TBL] [Abstract][Full Text] [Related]
5. Genetic association between ADAM10 gene polymorphism and Alzheimer's disease in a Northern Han Chinese population. Song JH; Yu JT; Liu M; Yan CZ; Tan L Brain Res; 2011 Nov; 1421():78-81. PubMed ID: 21959176 [TBL] [Abstract][Full Text] [Related]
6. Association analysis of Notch pathway signalling genes in diabetic nephropathy. Kavanagh D; McKay GJ; Patterson CC; McKnight AJ; Maxwell AP; Savage DA; Diabetologia; 2011 Feb; 54(2):334-8. PubMed ID: 21103979 [TBL] [Abstract][Full Text] [Related]
7. Lack of evidence to support the association of polymorphisms within the alpha- and beta-secretase genes (ADAM10/BACE1) with Alzheimer's disease. Laws SM; Eckart K; Friedrich P; Kurz A; Förstl H; Riemenschneider M Neurobiol Aging; 2011 Mar; 32(3):541-3. PubMed ID: 19344981 [TBL] [Abstract][Full Text] [Related]
9. Evidence against a role for rare ADAM10 mutations in sporadic Alzheimer disease. Cai G; Atzmon G; Naj AC; Beecham GW; Barzilai N; Haines JL; Sano M; Pericak-Vance M; Buxbaum JD Neurobiol Aging; 2012 Feb; 33(2):416-417.e3. PubMed ID: 20381196 [TBL] [Abstract][Full Text] [Related]
10. Contribution of putative genetic factors and candidate gene variants to inter-individual variation of circulating fractalkine (CX3CL1) levels in a large UK twins' sample. Franco L; Williams FM; Trofimov S; Surdulescu G; Spector TD; Livshits G Hum Immunol; 2013 Mar; 74(3):358-63. PubMed ID: 23261412 [TBL] [Abstract][Full Text] [Related]
11. Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity. Kim M; Suh J; Romano D; Truong MH; Mullin K; Hooli B; Norton D; Tesco G; Elliott K; Wagner SL; Moir RD; Becker KD; Tanzi RE Hum Mol Genet; 2009 Oct; 18(20):3987-96. PubMed ID: 19608551 [TBL] [Abstract][Full Text] [Related]
12. An association study on ADAM10 promoter polymorphisms and atherosclerotic cerebral infarction in a Chinese population. Li Y; Liao F; Yin XJ; Cui LL; Ma GD; Nong XX; Zhou HH; Chen YF; Zhao B; Li KS CNS Neurosci Ther; 2013 Oct; 19(10):785-94. PubMed ID: 23773531 [TBL] [Abstract][Full Text] [Related]
13. Impact of ADAM10 gene polymorphisms on hepatocellular carcinoma development and clinical characteristics. Shiu JS; Hsieh MJ; Chiou HL; Wang HL; Yeh CB; Yang SF; Chou YE Int J Med Sci; 2018; 15(12):1334-1340. PubMed ID: 30275760 [TBL] [Abstract][Full Text] [Related]
14. ADAM10 prodomain mutations cause late-onset Alzheimer's disease: not just the latest FAD. Vassar R Neuron; 2013 Oct; 80(2):250-3. PubMed ID: 24139026 [TBL] [Abstract][Full Text] [Related]
15. Family-based association analysis of alcohol dependence in the COGA sample and replication in the Australian twin-family study. Wang KS; Liu X; Aragam N; Jian X; Mullersman JE; Liu Y; Pan Y J Neural Transm (Vienna); 2011 Sep; 118(9):1293-9. PubMed ID: 21445666 [TBL] [Abstract][Full Text] [Related]
16. A Functional Polymorphism-Mediated Disruption of EGR1/ADAM10 Pathway Confers the Risk of Sepsis Progression. Chen F; Wang Y; Zhang W; Cai Y; Zhao T; Mai H; Tao S; Wei W; Li J; Chen X; Li X; Tang P; Fan W; Yang J; Ou M; Lu F; Lai Z; Chen H; Zou T; Sun F; Shao Y; Cui L mBio; 2019 Aug; 10(4):. PubMed ID: 31387910 [TBL] [Abstract][Full Text] [Related]
17. ADAM10 gene expression in the blood cells of Alzheimer's disease patients and mild cognitive impairment subjects. Manzine PR; Marcello E; Borroni B; Kamphuis W; Hol E; Padovani A; Nascimento CC; de Godoy Bueno P; Assis Carvalho Vale F; Iost Pavarini SC; Di Luca M; Cominetti MR Biomarkers; 2015; 20(3):196-201. PubMed ID: 26220620 [TBL] [Abstract][Full Text] [Related]
18. Association of CamK2A genetic variants with transition time from occasional to regular heroin use in a sample of heroin-dependent individuals. Eirich A; Biermann T; Müller CP; Kornhuber J; Benyamin B; Hulse GK; Wildenauer DB; Schwab SG Psychiatr Genet; 2019 Feb; 29(1):18-25. PubMed ID: 30260900 [TBL] [Abstract][Full Text] [Related]
19. The genetics of Alzheimer disease. Tanzi RE Cold Spring Harb Perspect Med; 2012 Oct; 2(10):. PubMed ID: 23028126 [TBL] [Abstract][Full Text] [Related]
20. Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma. Ko SY; Lin SC; Wong YK; Liu CJ; Chang KW; Liu TY Cancer Lett; 2007 Jan; 245(1-2):33-43. PubMed ID: 16309826 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]